Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | KCNB1 | Q14721 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | KCNB2 | Q92953 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6646552 | 0.80 | ALDH1A1 (0.45) | RAB9ANPC1MEN1KMT2APPARG | |
| SCHEMBL6649784 | 0.78 | NAMPT (0.53) | L3MBTL1RAB9ANPC1MEN1KMT2A | |
| SCHEMBL6647166 | 0.78 | KCNH2 (0.48) | L3MBTL1RAB9ANPC1MEN1KMT2A | |
| SCHEMBL6647175 | 0.76 | CA1 (0.50) | L3MBTL1RAB9ANPC1MEN1KMT2A | |
| SCHEMBL6644751 | 0.75 | NPC1 (0.52) | RAB9ANPC1MEN1KMT2AKDM4E | |
| SCHEMBL28413244 | 0.74 | KCNB1 (0.71) | RAB9ANPC1MEN1KMT2AKDM4E | |
| SCHEMBL6647603 | 0.74 | CTNNB1 (0.48) | L3MBTL1RAB9ANPC1KDM4ESMN1; SMN2 | |
| SCHEMBL6647504 | 0.73 | ALDH1A1 (0.46) | L3MBTL1RAB9ANPC1MEN1KMT2A | |
| SCHEMBL6645079 | 0.73 | KMT2A (0.51) | L3MBTL1RAB9ANPC1MEN1KMT2A | |
| SCHEMBL7134712 | 0.73 | KMT2A (0.51) | L3MBTL1RAB9ANPC1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040133008-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133008-A1 | Amide compounds | APOB, APOL1, LDLR | L3MBTL1 1609/4885RAB9A 3028/4885NPC1 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.